TransMedics Group, Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
TransMedics Group, Inc. (TMDX) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$5.33 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-04
- TransMedics Group, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was -$2.23M, a 199.96% decline year-over-year.
- TransMedics Group, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was -$3.10M.
- TransMedics Group, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $6.97M, a 199.74% increase year-over-year.
- TransMedics Group, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was $13.14M, a 163.66% increase year-over-year.
- TransMedics Group, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was $17.69M, a 122.90% increase from fiscal 2024.
- TransMedics Group, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was $7.94M, a 44.29% decline from fiscal 2023.
- TransMedics Group, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was $14.25M, a 314.61% increase from fiscal 2022.
- TransMedics Group, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was $3.44M, a 29.50% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$5.33M 10-Q · filed 2026-08-04 | $1.63M derived: sum of 3 quarters · filed 2026-08-04 | $14.77M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | -$3.10M 10-Q · filed 2026-05-05 | $3.86M derived: sum of 2 quarters · filed 2026-05-05 | $17.00M derived: sum of 3 quarters · filed 2026-05-05 | $19.23M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $6.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $20.11M derived: sum of 2 quarters · filed 2026-02-24 | $22.34M derived: sum of 3 quarters · filed 2026-08-04 | $17.69M 10-K · filed 2026-02-24 |
| 2025-09-30 | $13.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $15.37M derived: sum of 2 quarters · filed 2026-08-04 | $10.73M 10-Q · filed 2025-10-29 | $13.05M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $2.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$2.41M 10-Q · filed 2026-08-04 | -$89.00K derived: sum of 3 quarters · filed 2026-08-04 | $4.89M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | -$4.64M 10-Q · filed 2026-05-05 | -$2.32M derived: sum of 2 quarters · filed 2026-05-05 | $2.66M derived: sum of 3 quarters · filed 2026-05-05 | $3.34M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $2.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $7.31M derived: sum of 2 quarters · filed 2026-02-24 | $7.99M derived: sum of 3 quarters · filed 2026-02-24 | $7.94M 10-K · filed 2026-02-24 |
| 2024-09-30 | $4.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $5.66M derived: sum of 2 quarters · filed 2025-10-29 | $5.61M 10-Q · filed 2025-10-29 | $10.61M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $679.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $630.00K 10-Q · filed 2025-07-30 | $5.62M derived: sum of 3 quarters · filed 2026-02-24 | $10.68M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | -$49.00K 10-Q · filed 2025-05-08 | $4.94M derived: sum of 2 quarters · filed 2026-02-24 | $10.01M derived: sum of 3 quarters · filed 2026-02-24 | $10.75M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $4.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $10.05M derived: sum of 2 quarters · filed 2026-02-24 | $10.80M derived: sum of 3 quarters · filed 2026-02-24 | $14.25M 10-K · filed 2026-02-24 |
| 2023-09-30 | $5.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $5.80M derived: sum of 2 quarters · filed 2024-10-29 | $9.26M 10-Q · filed 2024-10-29 | $12.70M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $742.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $4.20M 10-Q · filed 2024-08-01 | $7.64M derived: sum of 3 quarters · filed 2025-02-27 | $7.88M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $3.45M 10-Q · filed 2024-05-02 | $6.90M derived: sum of 2 quarters · filed 2025-02-27 | $7.13M derived: sum of 3 quarters · filed 2025-02-27 | $6.89M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $3.44M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $3.68M derived: sum of 2 quarters · filed 2025-02-27 | $3.44M derived: sum of 3 quarters · filed 2025-02-27 | $3.44M 10-K · filed 2025-02-27 |
| 2022-09-30 | $234.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$4.00K derived: sum of 2 quarters · filed 2023-11-08 | -$8.00K 10-Q · filed 2023-11-08 | $2.51M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$238.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$242.00K 10-Q · filed 2023-08-04 | $2.28M derived: sum of 3 quarters · filed 2024-02-27 | $2.64M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$4.00K 10-Q · filed 2023-05-04 | $2.52M derived: sum of 2 quarters · filed 2024-02-27 | $2.88M derived: sum of 3 quarters · filed 2024-02-27 | $5.05M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $2.52M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $2.88M derived: sum of 2 quarters · filed 2024-02-27 | $5.05M derived: sum of 3 quarters · filed 2024-02-27 | $4.88M 10-K · filed 2024-02-27 |
| 2021-09-30 | $366.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $2.54M derived: sum of 2 quarters · filed 2022-11-04 | $2.36M 10-Q · filed 2022-11-04 | $984.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $2.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $1.99M 10-Q · filed 2022-08-03 | $618.00K derived: sum of 3 quarters · filed 2023-02-27 | $3.28M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | -$180.00K 10-Q · filed 2022-05-05 | -$1.55M derived: sum of 2 quarters · filed 2023-02-27 | $1.11M derived: sum of 3 quarters · filed 2023-02-27 | -$38.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | -$1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $1.29M derived: sum of 2 quarters · filed 2023-02-27 | $142.00K derived: sum of 3 quarters · filed 2023-02-27 | $1.95M 10-K · filed 2023-02-27 |
| 2020-09-30 | $2.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $1.51M derived: sum of 2 quarters · filed 2021-11-09 | $3.32M 10-Q · filed 2021-11-09 | $2.82M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$1.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $660.00K 10-Q · filed 2021-08-06 | $159.00K derived: sum of 3 quarters · filed 2021-05-07 | $2.30M derived: sum of 4 quarters · filed 2021-05-07 |
| 2020-03-31 | $1.81M 10-Q · filed 2021-05-07 | $1.30M derived: sum of 2 quarters · filed 2021-05-07 | $3.44M derived: sum of 3 quarters · filed 2021-05-07 | $1.86M derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-28 | -$501.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $1.64M derived: sum of 2 quarters · filed 2021-03-11 | $59.00K derived: sum of 3 quarters · filed 2021-03-11 | $2.45M 10-K · filed 2021-03-11 |
| 2019-09-28 | $2.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $560.00K derived: sum of 2 quarters · filed 2020-08-07 | $2.95M 10-Q · filed 2019-11-08 | |
| 2019-06-29 | -$1.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $816.00K 10-Q · filed 2020-08-07 | ||
| 2019-03-30 | $2.39M 10-Q · filed 2020-05-06 | |||
| 2018-12-29 | $2.34M 10-K · filed 2020-03-17 | |||
| 2018-09-29 | $1.80M 10-Q · filed 2019-11-08 | |||
| 2018-06-30 | -$603.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $1.09M 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $1.69M 10-Q · filed 2019-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |